drugset / Trial / NCT03558516

Magnesium and Intraoperative Blood Loss in Meningioma Surgery

NCT03558516

Phase 3 Completed 80 enrolled Mahidol University
RandomizedParallel-groupTriple-blindOther

Summary

Meningioma is the most common central nervous system tumor and craniotomy with tumor removal was associated with moderate blood loss and blood transfusion. Magnesium has hypotensive effect and probably reduce intraoperative blood loss. Whether or not magnesium sulphate can reduce intraoperative blood loss and improve postoperative cognitive function is still inconclusive. So the investigators conduct the randomized control trial to compare the effect of magnesium with placebo control in blood loss and cognitive function in meningioma patient undergoing craniotomy.

Timeline

Start
2018-08-01
Primary completion
2020-02-03
Completion
2020-02-18

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 10 mg/kg

Indications